Pain reduction induced by tapentadol in patients with musculoskeletal chronic pain fosters better sleep quality.

The reduction in pain intensity provided by tapentadol fosters sleep quality and favours a better quality of life. Therefore, our findings provide the rationale for addressing sleep quality as a relevant outcome, complementary to pain relief in CP management.